Literature DB >> 9638687

Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana.

P A Fried1, B Watkinson, R Gray.   

Abstract

Cognitive performance was examined in 131 9-12-year-old children for whom prenatal marihuana and cigarette exposure had been ascertained. The subjects, participants in an ongoing longitudinal study, were from a low-risk, predominantly middle class sample. The tasks included the WISC-III and a series of tests assessing aspects of cognition subsumed under the rubric of executive function. Consistent with results obtained at earlier ages, discriminant function analysis revealed a dose-dependent association, which remained after controlling for potential confounds (including secondhand smoke), between prenatal cigarette exposure and lower global intelligence scores with the verbal subtests of the WISC maximally discriminating among levels of in utero exposure. In contrast, prenatal marihuana exposure was not associated with global intelligence or the verbal subtests. Rather, this drug was negatively associated with the executive function tasks that require impulse control and visual analysis/hypothesis testing and with a number of WISC subtests requiring the same abilities. The interpretation of these results is discussed in terms of executive function and is related to earlier observations of this sample and to the extant prefrontal and general marihuana literature.

Entities:  

Mesh:

Year:  1998        PMID: 9638687     DOI: 10.1016/s0892-0362(97)00091-3

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  63 in total

1.  Maternal smoking during pregnancy and severe antisocial behavior in offspring: a review.

Authors:  Lauren S Wakschlag; Kate E Pickett; Edwin Cook; Neal L Benowitz; Bennett L Leventhal
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

2.  Executive functioning in preschool-age children prenatally exposed to alcohol, cocaine, and marijuana.

Authors:  Julia S Noland; Lynn T Singer; Robert E Arendt; Sonia Minnes; Elizabeth J Short; Cynthia F Bearer
Journal:  Alcohol Clin Exp Res       Date:  2003-04       Impact factor: 3.455

Review 3.  Does smoking by pregnant women influence IQ, birth weight, and developmental disabilities in their infants? A methodological review and multivariate analysis.

Authors:  M C Ramsay; C R Reynolds
Journal:  Neuropsychol Rev       Date:  2000-03       Impact factor: 7.444

4.  Substance use during pregnancy: time for policy to catch up with research.

Authors:  Barry M Lester; Lynne Andreozzi; Lindsey Appiah
Journal:  Harm Reduct J       Date:  2004-04-20

Review 5.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

6.  Is the intergenerational transmission of smoking from mother to child mediated by children's behavior problems?

Authors:  Jeremy N V Miles; Margaret M Weden
Journal:  Nicotine Tob Res       Date:  2012-02-07       Impact factor: 4.244

Review 7.  Consequences of prenatal toxin exposure for mental health in children and adolescents: a systematic review.

Authors:  Justin H G Williams; Louise Ross
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-01-02       Impact factor: 4.785

8.  Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana.

Authors:  Michael J Rivkin; Peter E Davis; Jennifer L Lemaster; Howard J Cabral; Simon K Warfield; Robert V Mulkern; Caroline D Robson; Ruth Rose-Jacobs; Deborah A Frank
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

Review 9.  Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.

Authors:  Didier Jutras-Aswad; Jennifer A DiNieri; Tibor Harkany; Yasmin L Hurd
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

Review 10.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.